Janni, W
Harbeck, N
Rack, B
Augustin, D
Jueckstock, J
Wischnik, A
Annecke, K
Scholz, C
Huober, J
Zwingers, T
Friedl, T W P
Kiechle, M
Article History
Received: 24 August 2015
Revised: 2 March 2016
Accepted: 5 March 2016
First Online: 31 March 2016
Competing interests
: WJ received research grants from Novartis, GSK, Amgen, Eisai, Roche, Teva, Pierre Fabre, and Janssen Diagnostics. BR received research grants from Sanofi-Aventis, Astra-Zeneca, Amgen, and Novartis and is on the advisory board of Amgen and Novartis. JH is on the advisory board of Sanofi-Aventis.